Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 465
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05198531 | To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal Cancer | ||
| NCT06621095 | Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001) | ||
| NCT02108756 | Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer Bleeding | ||
| NCT07564505 | A Clinical Trial of Taibowei® Adalimumab Injection in the Treatment of Chinese Pediatric Patients With Moderately to Severely Active Crohn's Disease | ||
| NCT05020639 | A Study of TQB3820 in Patients With Hematological Malignancies | ||
| NCT07037238 | An Open-Label, Single-Arm Exploratory Clinical Study of Everolimus for the Treatment of Vascular Malformations | ||
| NCT05353179 | Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers | ||
| NCT07406035 | A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis | ||
| NCT07708272 | QT Interval/Corrected QT Interval （QT/QTc） Clinical Study to Evaluate the Cardiac Safety of TQ05105 Tablets in Healthy Participants | ||
| NCT06829784 | TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection | ||
| NCT02403544 | Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma | ||
| NCT03624309 | Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer | ||
| NCT07738679 | Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With Advanced Solid Tumors | ||
| NCT04675060 | Effect of High-fat Meal on the Pharmacokinetics of TQ-B3139 Capsules | ||
| NCT04623333 | A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer | ||
| NCT05365178 | To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer | ||
| NCT04574284 | A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer | ||
| NCT02809534 | A Study of Anlotinib in Patients With Hepatocellular Carcinoma | ||
| NCT02332499 | Study of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703) | ||
| NCT06931145 | Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer | ||
| NCT04610970 | A Study of TQ-B3525 in Subjects With Relapse/Refractory Diffuse Large B-cell Lymphoma （DLBCL） | ||
| NCT06672263 | A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia | ||
| NCT06198764 | A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for Injection | ||
| NCT06106841 | TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL) | ||
| NCT04275050 | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets | ||
| NCT05045872 | Assessment of Renal Vasculature and Function with Ferumoxytol-enhanced Magnetic Resonance Imaging | ||
| NCT06160895 | A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects | ||
| NCT03735264 | Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer（ALTER-L034） | ||
| NCT05021367 | A Clinical Study of TQB3823 in Patients With Advanced Malignant Tumor | ||
| NCT04923607 | Phase I Clinical Trial of TQC2731 Injection | ||
| NCT07165951 | Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) | ||
| NCT05051930 | A Clinical Trial of TQC3721 Suspension for Inhalation | ||
| NCT05154630 | Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors | ||
| NCT06198751 | A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer | ||
| NCT06165809 | A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer | ||
| NCT02944864 | A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics | ||
| NCT06300320 | A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease | ||
| NCT04144855 | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3474 Injection | ||
| NCT03059797 | Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202) | ||
| NCT05494060 | XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma | ||
| NCT06143735 | A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors | ||
| NCT04012619 | Anlotinib Hydrochloride Combined With AP in Stage IIIB/IIIC/IV Non-squamous Non-small-cell Lung Cancer | ||
| NCT06943677 | A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in Subjects With Advanced Malignant Tumors | ||
| NCT04822805 | A Study of Anlotinib in the Treatment of Recurrent High-grade Glioma | ||
| NCT05476341 | A Phase I Clinical Trial of Bevacizumab Injection | ||
| NCT06475599 | Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer | ||
| NCT05121363 | A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial Carcinoma | ||
| NCT02072044 | Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs Therapy | ||
| NCT06798207 | A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced | ||
| NCT07633314 | A Clinical Trial Comparing TQC3927 Inhaled Powder With Glycopyrronium Bromide and Formoterol Inhaled Aerosol (Biovoping® Lingchang®) for the Treatment of Chronic Obstructive Pulmonary Disease |
